Dana dhuwit diétung saben saham OpGen, Inc. (OPGN)

Lambang korporat lan logo OpGen Corporation (OPGN)

The cash per share value demonstrates the liquidity of OpGen, Inc. (OPGN), which develops molecular tests to combat superbugs in hospital settings. The business model relies on the global implementation of diagnostic platforms coupled with the sale of high-margin consumables. Operations are strictly regulated by FDA standards regarding the disposal of biomaterials. Meanwhile, 0.00 captures the current value of the indicator, determining the level of capital security.

OPGN opgen.com: Dana dhuwit saben saham ing interval 04.07.2022 - 31.08.2024

Rincian metrik komprehensif lan analitis OpGen Corporation (OPGN)

- rega saiki lan proyeksi nilai saham:
- rincian posisi dhuwit lan arus kas:
Analisis komprehensif perusahaan:OpGen, Inc. OPGN
Produk seri OpGen Corp

OpGen, Inc. relies entirely on external contractors to conduct research and scale formulas. An analysis of cash per share allows for an assessment of the company's liquidity given the absence of its own manufacturing plants. This metric is calculated by dividing the total volume of highly liquid assets by the number of shares outstanding. Growth in this metric confirms the availability of reserves to pay for CRO services. A stable cash balance guarantees the operational sustainability of the R&D business.